Skip to content
Descubridor Institucional UMAR
Inicio
Búsqueda avanzada
Explorar
Inicio
Búsqueda avanzada
Explorar
Login
Language
English
Deutsch
Español
Français
Italiano
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
Evaluation of potential drug–drug interactions with medical cannabis
Evaluation of potential drug–drug interactions with medical cannabis
Fuente:
Wiley Open Access
Saved in:
Bibliographic Details
Main Authors:
Jessie Jia Yi Ho
,
Chenyi Goh
,
Caitlin Shen Ai Leong
,
Khuen Yen Ng
,
Athirah Bakhtiar
Format:
Artículo Open Access
Published:
Wiley
2024
Subjects:
Clinical and Translational Science
Online Access:
Acceder al recurso
Tags:
Add Tag
No Tags, Be the first to tag this record!
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Save to List
Permanent link
Holdings
Description
Comments
Similar Items
Staff View
Be the first to leave a comment!
Your Comment
You must be logged in first
Similar Items
Predictors of potential clinically harmful drug–drug interactions at the medical wards in the University of Benin Teaching Hospital, Benin City
by: Oseremen Godstime Oriaifo, et al.
Published: (2024)
Evaluation of drug–drug interactions of a novel potent FLT3 inhibitor SKLB1028 in healthy subjects
by: Jingcheng Chen, et al.
Published: (2024)
Proposing a framework to quantify the potential impact of pharmacokinetic drug–drug interactions caused by a new drug candidate by using real world data about the target patient population
by: Simon Dagenais, et al.
Published: (2024)
No drug–drug interactions between selective prolyl‐tRNA synthetase inhibitor, bersiporocin, and pirfenidone or nintedanib in healthy participants
by: Wonsuk Shin, et al.
Published: (2024)
A phase I drug–drug interaction study to assess the effect of futibatinib on P‐gp and BCRP substrates and of P‐gp inhibition on the pharmacokinetics of futibatinib
by: Amanda Long, et al.
Published: (2024)
